NCT07007156 Is a Positive NECPAL in ICU Patients Associated With Higher Mortality
| NCT ID | NCT07007156 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Consorci Sanitari de l'Alt Penedès i Garraf |
| Condition | Acute Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 199 participants |
| Start Date | 2025-06-12 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 199 participants in total. It began in 2025-06-12 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission
Eligibility Criteria
Inclusion Criteria: * Patients who meet all of the following inclusion criteria may be included in the study: * Men and women aged 75 years or older. * Admission to the ICU of the study center. * Legal capacity to provide informed consent. * Signed informed consent for study inclusion, either by the participant or their legal representative. Exclusion Criteria: Participants who meet any of the following exclusion criteria may not be included in the study: -Death within the first 24 hours of ICU admission.
Contact & Investigator
Diana Gutiérrez, MD
PRINCIPAL INVESTIGATOR
CSAPG
Frequently Asked Questions
Who can join the NCT07007156 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Acute Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07007156 currently recruiting?
Yes, NCT07007156 is actively recruiting participants. Contact the research team at dpgutierrez@csapg.cat for enrollment information.
Where is the NCT07007156 trial being conducted?
This trial is being conducted at Sant Pere de Ribes, Spain.
Who is sponsoring the NCT07007156 clinical trial?
NCT07007156 is sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. The principal investigator is Diana Gutiérrez, MD at CSAPG. The trial plans to enroll 199 participants.